tripelennamine has been researched along with Experimental Neoplasms in 2 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| POST, JT | 1 |
| Habs, M | 1 |
| Shubik, P | 1 |
| Eisenbrand, G | 1 |
2 other studies available for tripelennamine and Experimental Neoplasms
| Article | Year |
|---|---|
The incidence of pulmonary tumors in mice exposed to aerosols of therapeutic agents; an evaluation of the possible carcinogenic properties of penicillin, pyribenzamine, adrenalin, cortisone, trypsin and desoxyribonuclease.
Topics: Aerosols; Animals; Carcinogens; Cortisone; Deoxyribonucleases; Incidence; Lung Neoplasms; Mice; Neop | 1959 |
Carcinogenicity of methapyrilene hydrochloride, mepyramine hydrochloride, thenyldiamine hydrochloride, and pyribenzamine hydrochloride in Sprague-Dawley rats.
Topics: Adenoma; Adrenal Gland Neoplasms; Aminopyridines; Animals; Dose-Response Relationship, Drug; Female; | 1986 |